Of interest, a systems biology approach has previously been pursued to compute the potential mechanism of “VEGF feedback induction” by bevacizumab and was based on a whole-body pharmacokinetic model of blood, normal tissue, and tumor tissue [28]. Here, VEGFA is linked to neoplasm.